(Q37876422)

24 August 2017

1 reference

title

Pain management in the 21st century: utilization of pharmacogenomics and therapeutic drug monitoring (English)

1 reference

24 August 2017

0 references

1 reference

Paul J Jannetto

1

1 reference

PubMed ID

21585291

24 August 2017

Nancy C Bratanow

series ordinal

2

1 reference

PubMed ID

21585291

24 August 2017

language of work or name

English

0 references

publication date

1 June 2011

1 reference

Expert Opinion on Drug Metabolism & Toxicology

24 August 2017

1 reference

24 August 2017

7

1 reference

24 August 2017

6

1 reference

24 August 2017

745-752

1 reference

Morphine and alternative opioids in cancer pain: the EAPC recommendations

24 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Effect of genetic factors on opioid action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Pharmacogenetics of opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

The pharmacogenetics of analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Candidate gene polymorphisms predicting individual sensitivity to opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Utility and application of urine drug testing in chronic pain management with opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Clinical implications of opioid pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: genotyping cytochrome P450 2D6 for oxycodone cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Medical genetics: a marker for Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

The pharmocogenomics of warfarin: closing in on personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Pharmacogenomic analysis of cytogenetic response in chronic myeloid leukemia patients treated with imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Narrative review: the pathophysiology of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Alteration of serotonin transporter density and activity in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

Pharmacogenomic considerations in the opioid management of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

No Influence of ABCB1 Haplotypes on Methadone Dosage Requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.565051

10.1517/17425255.2011.565051

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21585291